Cannabinoid Medicine CME

Developed by TMCI Global and the Society of Cannabis Clinicians (SCC), the Clinical Cannabinoid Medicine Curriculum is the first comprehensive, online CME-certified curriculum designed to educate the practicing clinician on both the research and clinical practice aspects of the therapeutic use of cannabis.

While reviewing Clinical Cannabinoid Medicine Curriculum, you will learn:
• The fundamentals of the Endocannabinoid System
• The use of cannabis in a clinical setting
• The delivery and dosage of medical cannabis
• Mental health and the psychiatric application of medical cannabis

Clinical Cannabinoid Medicine Curriculum includes a bonus module on Cannabinoid Chemistry authored by Dr. Raphael Mechoulam, a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel and leading authority on Medical Cannabis science.

Target Audience:
All healthcare practitioners; the curriculum was designed to educate the practicing clinician on both the research and clinical practice aspects of the therapeutic use of cannabis.

This activity aims to assist healthcare professionals in understanding how cannabis can take its place in the medical world. It discusses medicinal cannabis’ uses, modes of administrations, mechanism of action, common drug interactions, and considerations for special populations.

The Iowa Comprehensive Medical Cannabis Course Bundle has been approved by the Iowa Department of Public Health’s Office of Medical Cannabidiol. This comprehensive medical cannabis educational course bundle helps doctors, nurses, pharmacists, psychologists and dentists prepare to care for patients using cannabis-based products, including CBD.

The Iowa Comprehensive Medical Cannabis Course Bundle introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses various aspects of medical cannabis, including administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided. This course bundle also addresses the use of cannabidiol (CBD) in clinical care, and the information will assist clinicians in effectively treating and counseling CBD consumers.

The physiological effects of CBD, CBD drug interactions, CBD’s side effects, and the conditions for which CBD has been shown by evidence-based clinical studies to be efficacious are all discussed in this course bundle.